The murine model of leishmaniosis is a prototypic example for the critical role played by T helper cells in immunity to pathogens. Cytokines, such as interleukin-12 and interleukin-4, are the major regulatory factors for differentiation of naive T helper cells into T helper 1 and T helper 2 cells, respectively. T helper 1 cells, which are cellular immune mechanisms involving gamma interferon production, are associated with protection against murine leishmaniosis. Loss of T helper 1 activity (i.e., reduced gamma interferon production and lack of macrophage activation) leads to a fatal progressive course of murine leishmaniosis.
Introduction
The availability of a series of inbred mouse strains offers an attractive opportunity to study immune responses against infectious agents in groups of genetically identical animals. Moreover, cytokine (receptor) gene-disrupted mouse mutants ('knockout [ko] mice') allow for a definitive analysis of important immunoregulatory molecules, such as cytokines.
The murine model of leishmaniosis is a prototypic example for the critical role played by T helper (Th) cells in immunity against micro-organisms. In 1986, Mosmann and Coffman reported on a functional diversity and different cytokine secretion patterns amongst two groups of murine CD4 + (cluster of differentiation antigen) T helper cell clones which have since been referred to as T helper 1 (Thl) and T helper 2 (Th2) cells (46). Thl cells characteristically produce interferon-y (IFN-y), interleukin-2 (IL-2) and tumour necrosis factor (TNF-ß), whereas Th2 cells characteristically produce a range of cytokines including IL-4, IL-5, IL-6, IL-9, IL-10 and IL-13 (1, 47, 48, 75) (Fig. 1) . Functionally, Thl responses mediate cellular immunity, which is important for protection against intracellular pathogens, whereas Th2 cells are responsible for humoral immunity, which confers protection against extracellular pathogens ( and those obtained from L. donovani infection. In addition, the authors summarise the current understanding of the genetic basis for Th phenotype development and associated disease resistance or susceptibility. Lastly, emerging data describing the Thl/Th2 paradigm in non-murine species, such as companion and livestock animals, will be summarised. 
Regulation of immune responses by T helper 1 and T helper 2 cells
the promastigotes transform into intracellular amastigotes, a developmental form which is retained in the vertebrate host. Clinical leishmanial infections range from self-healing, cutaneous to uncontrolled, diffuse cutaneous disease, from mild to highly destructive mucosal disease, and from subclinical to fatal systemic visceral disease. Infection of inbred strains of mice with L. major results in an array of responses (from control and resolution of infection to progressive and fatal disease) which represent experimental models for the different disease expression in humans (39, 65, 66) . In BALB/c and a few other non-healer mouse strains, local infection is not controlled effectively by the immune response and the disease disseminates to involve visceral organs, with an eventually fatal outcome (Fig. 4) . Infection of most other strains (e.g., 129/Sv/Ev, C3H/HeN, C57B176 mice), which have been termed 'healer strains', causes a localised lesion that heals spontaneously after a few weeks (Fig. 4) . The resolution of lesions is accompanied by the development of complete resistance to reinfection. 
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Major histocompatibility complex (MHC) class II-restricted CD4 + T cells are of critical importance for the development of clinical disease (27, 40, 68, 84) , whereas MHC class Irestricted CD8 + T cells are of minor importance during primary infection (88) . Cure and exacerbation of infection with L major has become a paradigm for the role of different T helper subsets during the infection (Fig. 4) . Healer and non-healer strains develop predominantly Thl and Th2 responses, respectively (27, 28, 39) . Amongst the factors influencing Thl or Th2 development, the local cytokine environment is of critical importance. Substantial evidence indicates that IL-12 and IL-4 are the major factors determining the capacity of primed CD4 + T cells to develop into Thl and Th2 cells, respectively. Moreover, IL-4 and IL-12 have been suggested to act in a cross-regulatory capacity and to mutually inhibit Th subset development, directly or indirectly, by IL-10 and IFN-y (30, 31, 74) . Depletion of IL-4 by neutralisation with monoclonal antibodies (mAbs) or soluble IL-4 receptor made susceptible mice resistant (17, 24, 69, 70) , and depletion of IFN-y by either mAb neutralisation or gene disruption rendered resistant mice susceptible to infection (4, 79, 89) . Neutralisation of IL-12, a cytokine promoting Th1 and suppressing Th2 development, abrogated resistance, whereas the supplementation of recombinant IL-12 (rIL-12) to susceptible mice allowed them to resolve infection (29, 73, 80) . Treatment with cytokines or antibodies proved to be effective only when given early during the first week of infection with L. major. This review focuses on more recent data obtained by the authors in laboratory studies of IL-12 ko mice as well as on recent data from IL-4 ko mice.
The high susceptibility of interleukin-12-deficient mice to infection with 
Leishmania major
Mice with homozygous disruption of either the IL-12p35 or IL-12p40 gene on a normally resistant background (129/Sv/Ev) failed to control infection with L. major and developed progressive disease, as determined by footpad swelling, ulceration of lesion and parasite titre (41 The ability of non-healer BALB/c mice to resist an infection consisting of a relatively small number of parasites and the association of this resistance with the development of stable cell-mediated immunity have been shown above. In addition, these mice acquired resistance to a larger, normally pathogenic rechallenge (13) . Thus, L. major infection of BALB/c mice can serve as an important in vivo model for vaccination regimens. To compare relative susceptibility and resistance between normally 'susceptible' BALB/c mice and IL-12-deficient mice on a resistant background, mice were infected with low numbers of parasites (43) . In keeping with results obtained by Bretscher et al (13) , BALB/c mice infected with a high dose of parasites (> 10 6 ) developed large lesions with a high parasite load, whereas low-dose (10 2 ) inocula resulted in late appearance of small lesions, which were eventually resolved. More than five months after infection, the number of viable parasites derived from the lymph nodes of these low-dose infected BALB/c mice was comparable to that obtained from resistant mice injected with a high dose. Infection of BALB/c mice with intermediate parasite doses (10 3 to 10 4 ) showed a 'milder' disease pattern based on parasite burden and a delay of lesion development which, however, could not be resolved. Concurrent with the decrease of parasite inocula was an increase in the IFN-y response in BALB/c mice. In contrast, IL-12-deficient 129/Sv/Ev mice were highly susceptible, regardless of the number of injected promastigotes. In comparing low-dose (100 parasites) infected BALB/c and IL-12-deficient mice, only the latter were found to develop ulcerating lesions and a 10 5 -fold increase in parasite load.
Taken together, these results confirmed those published previously by Bretscher et al, who demonstrated that susceptibility and Th2 development can be reversed in BALB/c mice infected with a low dose of L. major promastigotes (13) . In addition, the data obtained by the authors show the essential role of IL-12 in resistance to L. major. No compensatory pathway appears to exist for IL-12. Development of a protective type 1 response to even very low inocula is crucially dependent on IL-12. The new results emphasise that the major function of IL-12 is the induction of a protective Thl response rather than the suppression of a disease-promoting Th2 response.
The role of interleukin-4
During the last decade, the murine model of cutaneous leishmaniosis has become a paradigm, mainly due to the observation that susceptible BALB/c mice can be cured by distinct immune interventions, including: low-dose infection; sub-lethal irradiation; depletion of CD4 + T cells; neutralisation of IL-4 or IL-2; or treatment with cyclophosphamide, CTLA4-Ig (a fusion protein that, blocks the B7-CD28 interaction between antigen-presenting cells and T cells) or rlL-12. All these interventions had one immunological effect in common: the attenuation of the IL-4 response (66). Mice with a targeted disruption of the IL-4 gene (IL-4 ko mice) contained the infection and did not develop progressive disease (33) . Furthermore, in comparison to homozygous IL-4 wild-type mice, heterozygous lL-4 c+/-) animals consistently developed smaller lesions with less ulceration and necrosis, which indicates the likelihood of gene-dosage effects. This result suggests that the magnitude of the IL-4 response correlates directly with the severity of disease, as suggested earlier by studies which compared different inbred strains of all levels of susceptibility to disease (45). Seemingly conflicting results using the IL-4-deficient mice were obtained by Noben-Trauth et al. (57) , who reported that IL-4-deficient BALB/c mice remain as susceptible as wild-type mice. However, by comparing different L. major strains in lL-4-deficient mice, the authors arrived at the conclusion that the difference may lie in the various parasite strains used to infect the mice (42), although the mechanism by which particular parasite strains can regulate lesion development independent of an IL-4 response remains to be studied. Together, these results strongly indicate the following abilities in L. major-infected IL-4-deficient mice:
-the mice can control disease exacerbation, to a certain degree, independent of the parasite strain -the mice may develop quite massive lesions, depending on the virulence of the parasite strain -the mice are not as efficient at parasite control as a 'resistant' strain.
Indeed, this implies that IL-4 is not the only factor which determines susceptibility in BALB/c mice. Previous studies by other researchers have already suggested that the genetic traits which determine cure in L. major infection can direct disease outcome from both T-cell and non-T-compartments, and that the presence of the curing genotype in only one compartment is sufficient to confer cure (76) .
The early interleukin-4 response
Recent research has shown that, in contrast to resistant mice, susceptible BALB/c mice exhibit a peak of IL-4 messenger RNA (mRNA) extremely rapidly after infection with L. major (34) . Interestingly, NK1.1-CD4 + T cells were responsible for this rapid IL-4 response, which could be downregulated by IL-12 administered prior to the injection of parasites. Also, in contrast to wild-type (C57BL/6 x 129/Sv/Ev) F2 mice, susceptible IL-12-deficient mice exhibited an early peak of IL-4 mRNA either in the spleen 90 min after intravenous injection of parasites or in lymph nodes 16 h after subcutaneous injection (41) . Researchers discovered very recently that IL-4 produced very early in infection in susceptible BALB/c mice was derived from a restricted population of T-cell receptor (TCR) V|34 Vct8 (allele forms of the variable domains of the TCR (3-and a-chain) CD4
+ T cells after cognate interaction with a single antigen from L. major (35) . When BALB/c mice were depleted of Vß4-expressing T cells, resistance to infection was acquired (35) . This demonstrates that the early IL-4 response is decisive for Th2 development and the fatal outcome of infection, and also shows that IL-12 downregulates the early IL-4 response in genetically resistant mice.
Importance of T-cell cytokines in Leishmania donovani infection
The role of distinct T helper cell subsets in visceral leishmaniosis
The clinicopathological consequences of visceral leishmaniosis caused by L. donovani in humans are much more critical than those of cutaneous leishmaniosis caused by L. major. While L. major parasites remain locally restricted and induce chronic or self-limiting cutaneous infection, L donovani parasites disseminate through the blood circulation into the spleen, liver and, at a later stage, also into the bone marrow, which often results in a fatal outcome for the host (5; J. Lehmann, unpublished observations). Without therapeutical intervention, lethality following infection with L. donovani can reach 90% (22) ; hence the need to establish experimental animal models for the investigation of the pathogenesis of visceral leishmaniosis. Most current knowledge about the pathogenesis and the immune response to L. donovani infection originates from findings in the mouse model. As in cases of L. major infection, there is strong evidence that the immune response plays an important role in the outcome of the disease in addition to other genetic factors.
The following paragraphs summarise the main characteristics of the immune response to L. donovani.
To study the way in which the particular immune response in inbred or congenic mouse strains contributes to different courses of the disease, mice of certain H-2 haplotypes were infected with L. donovani. As with immunity to L. major, Thl responses to L. donovani are critical for protection. IFN-y undoubtedly acts as the key cytokine in resistance and cure during L. donovani infection (51, 52, 77) : the true functions of the other cytokines secreted during visceral leishmaniosis are less well understood. The IFN-y expression level and/or the number of IFN-y producers at the time of invasion and during L. donovani infection determine the immune response and the course of disease. Thus, resistant mice, such as the C3H/HeJ strain, are actually more potent in IFN-y production than susceptible mouse strains (37) . The importance of Thl cytokines in protection against fatal L donovani infection is underlined by the striking effect of IL-12 in this system. IL-12 was highly effective in curing L. donovani-infected BALB/c mice, whether applied at the beginning or at two weeks after infection (50, 55) . This is in contrast to L. major infection, where IL-12 was unable to cure BALB/c mice with a previously established Th2 response unless a leishmanicidal drug (pentavalent antimony) was administered (56) . Interestingly, the results also showed that in visceral leishmaniosis, the curing effect of IL-12 is mediated not only by the induction of IFN-y but also by the release of TNF-a, since IL-12 treatment also resulted in control of the disease in IFN-y ko mice. However, in either case the cytokine-induced leishmanicidal mechanism is nitric oxide (NO) production by the induction of inducible NO synthase (iNOS) (81) .
Although Thl responses are protective in both L. major and L. donovani infections, the role of Th2 responses appears to differ. Th2 cytokines, such as IL-4 or IL-5, were not found to be overexpressed in susceptible mouse strains (e.g., C57BI76 or BALB/c mice) upon infection with L. donovani (32, 37, 44) . Furthermore, neutralisation of IL-4 by the anti-murine IL-4 monoclonal antibody 1 IB11 or recombinant soluble murine IL-4 receptor failed to render susceptible mice resistant, or even to decrease parasite burdens significantly (44) . In this context, susceptibility to L. donovani infection may be a consequence of an insufficient Thl response rather than a dominant Th2 response. As recently reported by Satoskar et al., IL-4 ko mice did not reveal a resistant phenotype to L. donovani infection (71) . In contrast, their liver parasite burden at 15 days p.i. was significantly higher than the parasite burden of wild-type mice, which implies a protective rather than a pathological role for IL-4 in L. donovani infection. Indeed, Th2 cell-derived cytokines, such as IL-4 or IL-10, not only have suppressive effects on cellular immunity (10) but can also induce some cellular immune mechanisms under defined circumstances. Both IFN-y and IL-4 can activate the transcription factor STAT-1 (signal transducer and activator of transcription) in murine macrophages (36) and moreover, both are able to induce expression of MHC class II on murine macrophages (16, 20) and human monocytes (82) . Also, IL-4 treatment of murine macrophages resulted in increased tumoricidal activity (20; J. Lehmann, unpublished data) and, under certain circumstances, in enhanced leishmanicidal activity (9; J. Lehmann, unpublished data). IL-10 may induce gene expression of the high-affinity Fc receptor for IgG (FcyR I) as potently as IFN-y and furthermore may act synergistically with IFN-y (36, 83) . Thus, IL-10 is able to activate antibody-dependent cellular cytotoxicity, which represents an important mechanism to kill extracellular Leishmania parasites. As a whole, the role of Th2 cytokines in the murine model of L. donovani infection requires further studies. Since IL-4 and IL-10 do play a role in progressive human disease (25, 92) , it can be concluded that the role of Th2 cells may differ in murine and human L. donovani infection.
In contrast to the progressive course of L. major infection in genetically susceptible mouse strains, L. donovani infection in susceptible mice can reach a self-limiting state. As described below, the MHC haplotype of susceptible mice (e.g., C57BL/6, BALB/c, B10D2/n mice) determines the kinetics of the curing phenotype. Susceptible mouse strains were found, in principle, to be able to produce IFN-y, but the number of IFN-y producers appeared to be significantly lower than in resistant mice. The magnitude and the kinetics of the IFN-y response in susceptible strains correlated with the length of their healing periods. This further supports the assumption that IFN-y, which is produced mainly by Thl cells but also by CTLs (as described below), represents the decisive cytokine for resolution of L. donovani infection (37).
Interleukin-2 was also assumed to play a critical role in the cure of visceral leishmaniosis in susceptible mouse strains. This appeared to be less the result of an effect of IL-2 on IFN-y production than on the recruitment and activation of cytotoxic or suppressor T cells (Tc/s; CD8 + ). This assumption was based on CD8 + T-cell depletion experiments, which resulted in impaired resistance to rechallenge, whereas depletion of Th cells (CD4 + ) did not (53, 77) . These data conform with unpublished results obtained by the authors which show that CD8 + T cells from both C57BL/6 and BALB/c mice produced significant levels of IFN-y and IL-6 spontaneously and in response to Con A ex vivo, as well as to IL-2 and IL-10. However, the analysis of cytokine production of CD8 + T cells revealed some differences between quickly (C57B176) and slowly (BALB/c, B10D2/n) healing phenotypes. Surprisingly, CD8 + T cells from BALB/c mice have been found to be more potent in IFN-y production than those from C57BL/6, which was apparent both with and without Con A restimulation. Another interesting observation was that CD8 + T cells from C57BL/6 mice secreted significant levels of IL-2 only on day 30 p.i., whereas CD8 + T cells derived from BALB/c and B10D2/n mice did so on days 30 and 60 p.i., respectively (J. Lehmann, unpublished data). The latter result is consistent with the hypothesis that IL-2 is necessary to activate cytotoxic T cells during the stages of healing and establishment of immunity (53, 54) . However, both depletion of CD8 + T cells and depletion of CD4 + T cells inhibited development of resistance to L. donovani and impaired the tissue granulomatous response. Thus, either one of the T-cell subsets (Thl and Tc/s) is required for a successful immune response in experimental visceral leishmaniosis (78) . Nevertheless, the role played by different cytokines derived from CD8 + T cells in the immunoregulation of visceral leishmaniosis remains unclear. In particular, the importance of IFN-y, IL-6 and IL-10 should be studied in more detail. Summarising these data, even in susceptible mouse strains a protective immune response to L. donovani infection develops after the first 30 days of the exacerbation stage. This delayed protective response of susceptible mice involves different regulatory and effector mechanisms, mediated by Thl, Th2, and also Tc/s.
In experimental L. major infection, mice of a relatively resistant haplotype (e.g., C3H7HeN) produced high amounts of IFN-y in the very early stage of infection (within the first three days). The IFN-y was shown to be produced mainly by natural killer (NK) cells and the NK cell response is associated with decreased parasite numbers during the early stage of infection (72) . These low numbers of L. major parasites might be essential to induce a protective Thl cell response (13, 42, 72) . Spleen cells derived from L. donovani -infected C3H/HeJ mice (relatively resistant phenotype with low parasite burdens in the spleen and liver) produced significantly higher levels of IFN-y than spleen cells from C57BI76 or BALB/c mice, which implies a role for NK cells in the early innate defence against L donovani too (37). On the other hand, NK cells appeared to play only a minimal role in adaptive immunity against L donovani. NK cell depletion with anti-asialo GM1 antiserum did not significantly increase liver parasite burden in rechallenged immune BALB/c mice. In addition, previously infected beige mice with a C57BL/6 background, known for their defect in NK cell activity, resisted rechallenge as readily as wild-type C57BI76 mice.
Genetic basis for susceptibility versus resistance
Most mouse strains are able to heal L. major infection: only a few (BALB/c, BALB/b, BALB/k, DBA/2, SWR/J, C57BL/10ScCr mice) are genetically susceptible (49) . Interestingly, regardless of the genetic predisposition for susceptibility, there is no evidence for an irreversible form of leishmaniosis which could not be overcome by immunomodulation to date. So, what is the exact basis for the genetically determined inability of susceptible mouse strains to heal L major infection? The inability is not due to MHC genes. Most studies point to loci controlling either macrophage activation (e.g., production of NO) or development of Th phenotype. Although one report suggests that a single gene controls resistance in mice (21), more recent studies point to the multigenetic nature of resistance versus susceptibility in L. major infection. Susceptibility locus 1 (Scl1) on chromosome 11 was implicated in controlling earlier phases of L. major infection. Mouse chromosome 11 was implicated with candidate genes such as nos2 encoding iNOS, several monokines (macrophage chemotactic protein, macrophage inhibitory protein) and the chemokine RANTES (regulated upon activation, normal T expressed, and presumably secreted). The Th2 cluster on chromosome 11 which encodes IL-4, IL-5, IL-9 and IL-12p40 may be involved in controlling later phases of L. major infection. In addition, another unrelated gene locus on chromosome 11, designated T-cell phenotype modifier 1 (Tpml), has been found to be involved in the control of lymphocyte IL-12 responsiveness (26). Roberts et al. demonstrated linkage to a chromosome 9 locus (Leishmania major resistant 2: Lmr2) and to a region which includes the H-2 locus on chromosome 17 (Lmrl) (67) . By serial backcross mapping, Beebe et al. identified six loci associated with resistance to L. major (3) . Loci on chromosomes 6, 7, 10, 11, 15 and 16 were found. However, the presence of all six loci was not necessary to confer resistance and no single locus was required, which clearly shows the genetic complexity of the healer phenotype.
The outcome of L donovani infection in mice differs from murine L. major infection in that the former is under the control of both non-MHC II and MHC II genes in the early and late phase of infection, respectively (8) . The gene within the non-MHC II locus (Lsh/Ity/Bcg locus) on mouse chromosome 1 controls resistance to L. donovani and other intracellular microbes (Salmonella and Mycobacterium) in the first 2-3 weeks of infection, and its mutated allele confers susceptibility (Lshs, Natural resistance-associated macrophage protein lAsp 169 [Nrampl 169 ]) (11, 12) . Thus, Lshs mouse strains are unable to restrict the parasite growth during the early period of infection. However, the Lsh gene is unrelated to control of L. major. Recently, the gene product was identified as an integral membrane transport protein believed to be involved in L-arginine import required to support NO synthesis (2, 6, 86) . This finding might be of outstanding importance, since NO has been identified to be the most effective defence mechanism against Leishmania (38 or determine a slowly curing phenotype (e.g., BALB/c, B10D2/n mice) (7, 8) .
Importance of T helper 1 and T helper 2 cells in infections of companion and food animals
Importance of Th1 and Th2 cells in veterinary medicine
Until recently, work on cytokines and Thl/Th2 development was dominated by murine and human studies. Lack of reagents in companion and farm animals has been the major obstacle for analysis of T-cell-dependent cytokine profiles during infections of these species. However, there are some examples for the characterisation of Thl and Th2 profiles in small and large animal species.
Infection of dogs with Leishmania infantum
Pinelli et al. were able to correlate distinct Thl or Th2 patterns with an asymptomatic or symptomatic course, respectively, of L. infantum infection of dogs (62, 63) . Resistant dogs showed a strong cellular immune response but no humoral response to L. infantum antigen, whereas susceptible dogs developed a predominantly humoral response. Moreover, results from experimentally infected dogs were very similar to data obtained from naturally infected dogs. Therefore, Pinelli et al. propose the use of serum antibody titres, antigen-specific proliferative responses, delayed-type hypersensitivity skin reactions and the cytokines produced by peripheral mononuclear cells as markers of disease progression.
Feline infectious peritonitis
In the pathogenesis of feline infectious peritonitis (F1P), immunopathological mechanisms play a major role. FIP-specific antibodies did not protect against infection of macrophages, which are the target cells of the virus, but rather enhanced infection. Hyperplastic B-cell regions (90) , polyclonal B-cell activation leading to hypergammaglobulinaemia, elevated IL-6 levels in sera and ascites from FIP-infected cats are indicative of a predominant Th2 response (58) . There is evidence that cell-mediated immunity is protective against infection with FIP virus. Resistant cats developed strong DTH responses and only low titres of antibodies (23) . Low-dose immunisation which, as described earlier, was able to induce cellular immunity, could protect cats from a challenge infection (61) . Current prophylactic and therapeutic strategies are directed at inducing strong cell-mediated immunity against FIP virus and thereby favouring the development of a protective Thl response.
Feline immunodeficiency virus infection
Within days after feline immunodeficiency virus (FIV) infection, cytokine expression starts to change. Ultimately, inability to develop a Thl response against intracellular pathogens leads to a series of viral, fungal and parasitic opportunistic infections in FIV-infected cats. As with the human acquired immune deficiency syndrome (AIDS), Th2 development may be involved in the disease progression of cats infected with FIV (19) . This is based on observations of infected cats showing predominant B-cell responses and only weak cellular immunity (91).
Bovine leukaemia virus infection
In cattle infected with bovine leukaemia virus (BLV), which is the causative agent of enzootic bovine leukosis, different stages of the disease are known. Seropositive animals may develop persistent lymphocytosis, a disorder characterised by an increase in circulating B lymphocytes. Peripheral blood mononuclear cells from infected cattle with persistent lymphocytosis have been shown to produce elevated levels of IL-10 mRNA but reduced levels of IL-2 and IFN-y as compared to alymphocytotic animals (64) . Interestingly, IL-10 was produced by monocytes/macrophages. In addition, impaired proliferation of CD4 + T cells in response to gag-and env-encoded BLV proteins was found in BLV-infected cattle with persistent lymphocytosis (59) . This suggests that development of B-cell lymphocytosis along with a type 2 cytokine profile and loss of cellular immunity might be operative in the pathogenesis of enzootic bovine leukosis.
T helper responses in parasite infections of cattle
Analysis of Th responses in other infections of cattle revealed Fasciola hepatica-specific Th0 and Th2 cells, as well as Babesia bovis-specific Th0 and Thl (14, 15) . These observations agree with the hypothesis that Thl and Th2 responses are protective against intracellular and extracellular pathogens, respectively (Fig. 1) . However, most of the Th clones found show a Th0 phenotype co-expressing IL-4 and IFN-y. Therefore, it appears that Thl and Th2 clones are extremes within a broader spectrum of cytokine-expressing Th clones, at least for these infections of cattle. In addition, IL-10 was found to cause downregulation for all subtypes of bovine Th cells in a way similar to human IL-10 but different from murine IL-10, which specifically suppresses Thl cells. While these data are interesting, a correlation of a certain cytokine profile with resistance or susceptibility remains to be demonstrated. 
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